|
|
Volumn 45, Issue 1-3, 2001, Pages 171-173
|
|
Assessment of teratogenic risk
|
|
Author keywords
Antiepileptic drugs; Congenital malformations; Pregnancy; Teratogenesis; Women
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONGENITAL MALFORMATION;
DOSE RESPONSE;
DRUG EFFECT;
DRUG SCREENING;
EPILEPSY;
FEMALE;
FOLLOW UP;
HUMAN;
INFORMATION PROCESSING;
INTERNATIONAL COOPERATION;
INTRAUTERINE GROWTH RETARDATION;
PREGNANCY;
PRENATAL EXPOSURE;
PRIORITY JOURNAL;
QUALITY CONTROL;
REGISTER;
STUDY;
TERATOGENICITY;
ABNORMALITIES, DRUG-INDUCED;
ANTICONVULSANTS;
CLINICAL TRIALS;
FEMALE;
HUMANS;
PREGNANCY;
RESEARCH DESIGN;
RISK ASSESSMENT;
TERATOGENS;
|
|
EID: 0034914397
PISSN: 09201211
EISSN: None
Source Type: Journal
DOI: 10.1016/S0920-1211(01)00248-0 Document Type: Conference Paper |
|
Times cited : (10)
|
|
References (9)
|
